These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 29687326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA, García-Molina M, Gamboa Ó.
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Lundkvist J.
    Am Heart J; 2005 Feb; 149(2):298-303. PubMed ID: 15846268
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
    De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández F, Lamotte M.
    J Med Econ; 2016 Dec 01; 19(2):158-68. PubMed ID: 26451530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S, Lazzeri C, Giglioli C, Margheri M, Comeglio M, Nicolaci L, Chechi T, Gensini GF.
    J Cardiovasc Med (Hagerstown); 2006 Oct 01; 7(10):737-41. PubMed ID: 17001234
    [Abstract] [Full Text] [Related]

  • 12. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM, Malik JA, Manske CL, Kasiske BL, Dickinson SE, Herzog CA, Wilson RF, Das G, Panetta CJ.
    J Invasive Cardiol; 2005 Apr 01; 17(4):211-5. PubMed ID: 15831975
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P, Persson PB, Hansell P, Lagerqvist B.
    Kidney Int; 2006 Nov 01; 70(10):1811-7. PubMed ID: 17003814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Alexopoulos E, Spargias K, Kyrzopoulos S, Manginas A, Pavlides G, Voudris V, Lerakis S, McLean DS, Cokkinos DV.
    Am J Med Sci; 2010 Jan 01; 339(1):25-30. PubMed ID: 19996728
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.